Scotland · NHS Scotland MSAN
Imiquimod (Aldara® 5% and Bascellex® 50mg/g) cream 250mg sachets
MSAN(2024)66 · Level 2 · issued 11 Dec 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Imiquimod (Aldara®) 5% cream 250mg sachets are out of stock until mid-January 2025. | Out of stock | mid-January 2025 |
| 2. Imiquimod (Bascellex®) 50 mg/g cream 250mg sachets are out of stock until early January | Out of stock | early January |
| 3. Podophyllotoxin (Warticon®) 0.15% cream is out of stock until late January 2025 (see also | Out of stock | late January 2025 |
| 4. Efudix® (fluorouracil 5%) cream remains available, however it cannot support an uplift in | Available — cannot support uplift | — |
| 5. Alternative products remain available, and where these are not suitable, unlicensed supplies | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.